Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Schwarzschild

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Neurology|August 3, 2012
Caffeine in Parkinson disease: better for cruise control than snooze patrol?Michael A Schwarzschild
The New England Journal of Medicine|February 27, 2010
Rasagiline in Parkinson's diseaseMichael A Schwarzschild
Journal of Parkinson'S Disease|December 31, 2016
Could MAO-B Inhibitor Withdrawal Rather than Nilotinib Benefit Explain the Dopamine Metabolite Increase in Parkinsonian Study Subjects?Michael A Schwarzschild
Neurology|November 25, 2010
The delayed-start study in Parkinson disease: can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?Michael A Schwarzschild
Progress in Neurobiology|November 13, 2007
Adenosine A2A antagonists as neurotherapeutics: crossing the bridgeMichael A Schwarzschild
Brain Research|April 1, 2014
Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's diseaseAnil Kachroo, Michael A Schwarzschild
Science'S STKE : Signal Transduction Knowledge Environment|January 16, 2003
DARPP chocolate: a caffeinated morsel of striatal signalingElena Bastia, Michael A Schwarzschild
The Lancet. Neurology|October 19, 2016
The epidemiology of Parkinson's disease: risk factors and preventionAlberto Ascherio, Michael A Schwarzschild
Annals of Neurology|February 28, 2012
Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's diseaseAnil Kachroo, Michael A Schwarzschild
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 21, 2016
Urate as a Marker of Risk and Progression of Neurodegenerative DiseaseSabrina Paganoni, Michael A Schwarzschild
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Neurology|August 3, 2012
Caffeine in Parkinson disease: better for cruise control than snooze patrol?Michael A Schwarzschild
The New England Journal of Medicine|February 27, 2010
Rasagiline in Parkinson's diseaseMichael A Schwarzschild
Journal of Parkinson'S Disease|December 31, 2016
Could MAO-B Inhibitor Withdrawal Rather than Nilotinib Benefit Explain the Dopamine Metabolite Increase in Parkinsonian Study Subjects?Michael A Schwarzschild
Neurology|November 25, 2010
The delayed-start study in Parkinson disease: can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?Michael A Schwarzschild
Progress in Neurobiology|November 13, 2007
Adenosine A2A antagonists as neurotherapeutics: crossing the bridgeMichael A Schwarzschild
Brain Research|April 1, 2014
Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's diseaseAnil Kachroo, Michael A Schwarzschild
Science'S STKE : Signal Transduction Knowledge Environment|January 16, 2003
DARPP chocolate: a caffeinated morsel of striatal signalingElena Bastia, Michael A Schwarzschild
The Lancet. Neurology|October 19, 2016
The epidemiology of Parkinson's disease: risk factors and preventionAlberto Ascherio, Michael A Schwarzschild
Annals of Neurology|February 28, 2012
Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's diseaseAnil Kachroo, Michael A Schwarzschild
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 21, 2016
Urate as a Marker of Risk and Progression of Neurodegenerative DiseaseSabrina Paganoni, Michael A Schwarzschild
Pageof 24